Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Equity Average (2024 - 2025)

Historic Equity Average for Immunocore Holdings (IMCR) over the last 2 years, with Q3 2025 value amounting to $392.5 million.

  • Immunocore Holdings' Equity Average rose 652.42% to $392.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $392.5 million, marking a year-over-year increase of 652.42%. This contributed to the annual value of $364.8 million for FY2024, which is 308.2% up from last year.
  • Immunocore Holdings' Equity Average amounted to $392.5 million in Q3 2025, which was up 652.42% from $383.5 million recorded in Q2 2025.
  • Immunocore Holdings' Equity Average's 5-year high stood at $392.5 million during Q3 2025, with a 5-year trough of $359.3 million in Q2 2024.